anti-C100-3

Known as: anti C100-3 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2010
01219922010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
VARLYAKOV, I., N. GRIGOROVA and T. SLAVOV, 2010. Effect of Hostazym C 100 on growth performance and some hematological and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
The aims of this study were to identify the effect of clofibrate administration in the development of high blood pressure… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1994
1994
BACKGROUND The safety of intravenous immunoglobulin (IGIV), manufactured from units testing negative for antibody to hepatitis C… (More)
Is this relevant?
1993
1993
The mortality and morbidity rates of chronic liver disease (CLD) have been extremely high for several years at Saga prefecture in… (More)
Is this relevant?
1992
1992
Anti-c100-3 (Ortho) was determined in the sera of 152 patients with HBs antigen-positive chronic liver diseases to assess… (More)
  • table 2
  • table 3
  • figure 1
  • table 4
  • table 5
Is this relevant?